StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Highlights  
 
  Updates  
 
 
 
Amgen
280.33
+2.37%
 

AMGN

 

Amgen

$ 280.33

 
+$6.50 | +2.37%
 
 
Open
$ 276.50
 
 
MKT CAP
$ 150.23B
 
High
$ 281.93
 
 
VOL
$ 3.77M
 
Low
$ 274.88
 
 
AVG VOL
$ 3.33M
 
 
 

AMGN Stock Analysis

  Login to display Amgen (AMGN) recommendation from the last 90 days from financial news and social media.
 
 

AMGN Total Score

 
 

Strengths

AMGN Rewards

 Earnings are forecast to grow

AMGN Rewards

 Investors confidence is positive

AMGN Rewards

 Trading below its fair value

AMGN Rewards

 Analysts raised price target

 
 

Chart

 
 

307.81

272.45

280.6

228.43

 
 
1month
3month
6month
1year
 

AMGN Risk Level

This Indicator assigning AMGN risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
AMGN Risk Level
LOW
HIGH

Risk Volatility

 

AMGN has Low Risk Level

Click here to check what is your level of risk

 

AMGN Analysts Opinion

AMGN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.80
 

AMGN Earnings Sentiment

 Above analyst estimates

AMGN Earnings Sentiment

 Earnings increase YoY

AMGN Earnings Sentiment

 Sales increase

 
 

Rating

×
 

Rating

2.00
 
 

Momentum

×
 

Momentum

3.55
 

AMGN Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

3.75
 

AMGN Activity Sentiment

 Investors confidence is positive

AMGN Activity Sentiment

 Pays a reliable dividend

 

Future

×
 

Future

2.89
 

AMGN Future Sentiment

 Earnings are forecast to grow

AMGN Future Sentiment

 Trading below its fair value

AMGN Future Sentiment

 Analysts raised price target

 
 

AMGN Analysts Opinion

AMGN Analysts opinion is negative and has getting worse from the past 3 months

 

AMGN Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
72%
Buy
Opinion
Trend
Score
Potential
Score
 
 
0%
64%
58%
 
On Track
On Track
On Track
 

AMGN Street Opinion 

AMGN Street view is bullish but have mixed views on the near-term outlook

 

AMGN Performance Sentiment

Sentiments overview associated with AMGN events and the stock performance.
 
72%
20%
Positive
Negative
50 out of 69
events present
14 out of 69
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

AMGN Earnings

The TTM reflects 12-month period, providing review of AMGN financial performance.

 
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
26,833
26,323
25,979
+1.63%
 
 
Cost of Revenue
7,086
6,406
6,454
+4.78%
 
 
Gross Profit
19,747
19,917
19,525
+0.57%
 
 
Operating Exp
10,891
10,351
10,381
+2.43%
 
 
Operating Inc
8,856
9,566
9,144
-1.59%
 
 
Net Interest Inc
-2,469
-1,406
-1,197
-
 
 
Interest Exp
2,469
1,406
1,197
+43.62%
 
 
Interest Inc
-
-
-
-
 
 
Other Income
2,364
-814
-1,246
-
 
 
EPS
14.14
12.18
10.34
+16.94%
 
 
Next Earnings Date: Apr 25, 2024
 
 
Similar to AMGN
Total Score
Close Price
%
Change

NVO

Novo Nordisk A/S Com

3.61

124.23

+3.72%

 
 
 
Highlights
Last Modify
Price
% Change

 
Options Activity
1 Week Ago
283.51
-0.07%
 
Dividend Declares
2 Weeks Ago
290.48
-1.34%
 
Investors Buying
2 Weeks Ago
294.43
+1.14%
 
Options Activity
3 Weeks Ago
291.12
-1.27%
 
Strong Earnings
3 Weeks Ago
295.87
-6.39%
 
 
 
joker
 
 
 
StocksRunner

Explore our AMGN Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our AMGN Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 

AMGN Rewards

 Earnings are forecast to grow

AMGN Rewards

 Investors confidence is positive

AMGN Rewards

 Trading below its fair value

AMGN Rewards

 Analysts raised price target

 
 
 

AMGN Risk Level

 
 
 

The Indicator assigning AMGN risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
AMGN Risk Level
LOW
HIGH

Risk Volatility

 

AMGN has Low Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

AMGN

 

Amgen

$ 280.33

 
+$6.50 | +2.37%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 276.50
 
 
MKT CAP
$ 150.23B
 
High
$ 281.93
 
 
VOL
$ 3.77M
 
Low
$ 274.88
 
 
AVG VOL
$ 3.33M
 
 
 

AMGN Analysis

  Sign in to view Amgen (AMGN) recommendation from the last 90 days from financial news and social media.
 
 

Chart

 
 

307.81

272.45

280.6

228.43

 
 
1month
3month
6month
1year
 

AMGN Analysts Opinion

AMGN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

3.80
 

AMGN Earnings Sentiment

 Above analyst estimates

AMGN Earnings Sentiment

 Earnings increase YoY

AMGN Earnings Sentiment

 Sales increase

 
 

Rating

×
 

Rating

2.00
 
 

Momentum

×
 

Momentum

3.55
 

AMGN Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

3.75
 

AMGN Activity Sentiment

 Investors confidence is positive

AMGN Activity Sentiment

 Pays a reliable dividend

 

Future

×
 

Future

2.89
 

AMGN Future Sentiment

 Earnings are forecast to grow

AMGN Future Sentiment

 Trading below its fair value

AMGN Future Sentiment

 Analysts raised price target

 
 

AMGN Analysts Opinion

AMGN Analysts opinion is negative and has getting worse from the past 3 months

 

AMGN Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
72%
Buy
Opinion
Trend
Score
Potential
Score
 
 
0%
64%
58%
 
On Track
On Track
On Track
 

AMGN Street Opinion 

AMGN Street view is bullish but have mixed views on the near-term outlook

 
AMGN Performance Sentiment
Sentiments overview associated with AMGN events and the stock performance.
 
72%
20%
Positive
Negative
50 out of 69
events present
14 out of 69
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 

AMGN Earnings

The TTM data reflects the most recent 12-month period, providing overview of AMGN financial performance.

 
Millions of Dollars
TTM
2022
2021
CAGR
 

 
Total Revenue
26,833
26,323
25,979
+1.63%
 
 
Cost of Revenue
7,086
6,406
6,454
+4.78%
 
 
Gross Profit
19,747
19,917
19,525
+0.57%
 
 
Operating Exp
10,891
10,351
10,381
+2.43%
 
 
Operating Inc
8,856
9,566
9,144
-1.59%
 
 
Net Interest Inc
-2,469
-1,406
-1,197
-
 
 
Interest Exp
2,469
1,406
1,197
+43.62%
 
 
Interest Inc
-
-
-
-
 
 
Other Income
2,364
-814
-1,246
-
 
 
EPS
14.14
12.18
10.34
+16.94%
 
 
Next Earnings Date: Apr 25, 2024
 
Highlights
Last Modify
Price
% Change

 
Options Activity
1 Week Ago
283.51
-0.07%
 
Dividend Declares
2 Weeks Ago
290.48
-1.34%
 
Investors Buying
2 Weeks Ago
294.43
+1.14%
 
Options Activity
3 Weeks Ago
291.12
-1.27%
 
Strong Earnings
3 Weeks Ago
295.87
-6.39%
 
 
AMGN Latest News Feed

Dow Movers: UNH AMGN. In early trading on Friday shares of Amgen topped the list of the days best performing Dow Jones Industrial Average components trading up 1.4%. Year to date Amgen has lost about 3.5% of its value.And the worst performing Dow component thus far on the day is UnitedHealth G

Fri Mar 1, 2024

Momentum
Momentum

Amgens Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets Says Goldman Sachs. ) is expected to unveil updates on various programs this year. Despite concerns about the company’.s long-term growth amid exclusivity losses Goldman Sa

Mon Feb 26, 2024

Activity
Activity
Potential
Potential

F.T.C. Sues to Block Kroger-Albertsons Grocery Store Deal. The Federal Trade Commission on Monday sued to block Kroger the supermarket giant from completing its $24.6 billion acquisition of the grocery chain Albertsons saying the deal would hurt competiti

Mon Feb 26, 2024

Activity

Amgen (AMGN) Price Target Increased by 6.83% to 313.74. The average one-year price target for Amgen (NasdaqGS:AMGN) has been revised to 313.74 / share. This is an increase of 6.83% from the prior estimate of 293.67 dated January 16 2024. The p

Sat Feb 24, 2024

Potential

Notable Tuesday Option Activity: AMGN GOOG AXSM. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Amgen Inc (Symbol: AMGN) where a total volume of 16292 contracts has been t

Tue Feb 20, 2024

Momentum

The margin of safety: the ten-billion-dollar lesson from Amgen. A notable book that emphasized the importance of corporate culture by looking at successful companies (stock price performance as a guide) ranked Amgen prominently. Amgens adeptness in embrac

Tue Feb 20, 2024

Activity
Potential

Recombinant Proteins Market Predicted to Garner US$ 704.6 Bn By 2033 At CAGR 13.5%. New York Feb. 20 2024 (GLOBE NEWSWIRE) -- The recombinant proteins market was valued at USD 205.0 billion in 2023 with significant growth and is projected to reach at USD

Tue Feb 20, 2024

Potential

If You Invested $20000 in Amgen in 2014 This Is How Much You Would Have Today. Amgen (NASDAQ: AMGN) is one of the largest drug manufacturers in the world with a market cap of more than $150 billion. It pays a dividend has been growing steadily o

Sat Feb 17, 2024

Potential

Ex-Dividend Reminder: Royalty Pharma Amgen and Jefferies Group. Looking at the universe of stocks we cover at Dividend Channel on 2/15/24 Royalty Pharma plc (Symbol: RPRX) Amgen Inc (Symbol: AMGN) and Jefferies Group Inc. (Symbol: JEF) will

Tue Feb 13, 2024

Activity

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It. Amgen (AMGN) has recently been on Zacks.coms list of the most searched stocks. Therefore you might want to consider so

Mon Feb 12, 2024

Activity

amgen to present at the 34th annual oppenheimer healthcare life sciences conference. thousand oaks calif. feb. 9 2024 /prnewswire/ -- amgen (nasdaq:amgn) will present at the 34th annual oppenheimer healthcare life sciences conference at 12:00 p.m. et on w

Fri Feb 9, 2024

Activity

notable friday option activity: amgn incy mu. among the underlying components of the s&.p 500 index we saw noteworthy options trading volume today in amgen inc (symbol: amgn) where a total of 19888 contracts have traded so far representin

Fri Feb 9, 2024

Momentum

amgen: weight loss drug candidate debate a red herring - buying the dip advisable.

Thu Feb 8, 2024

Momentum

amgens weight-loss results are a bit underwhelming says lilly executive.

Wed Feb 7, 2024

Activity

amgen stock suffers worst day in over 2-1/2 years as analysts debate weight loss prospects.

Wed Feb 7, 2024

Potential

investors focus around amgens obesity drug data shadows better than expected q4 earnings. tuesday) reported its fourth quarter 2023 adjusted net profit increased 15% to $4.71 beating the consensus of $4.62 driven by increased revenues partially offset. f

Wed Feb 7, 2024

Earnings

amgen (amgn) q4 earnings top horizon drugs drive sales. amgen amgn reported fourth-quarter 2023 adjusted earnings of $4.71 per share which beat the zacks consensus estimate of $4.66. earnings r

Wed Feb 7, 2024

Earnings

amgen cut at leerink on heavy obesity expectations.

Wed Feb 7, 2024

Rating

amgen (amgn) q4 earnings and revenues top estimates. amgen (amgn) came out with quarterly earnings of $4.71 per share beating the zacks consensus estimate of $4.66 per share. this compares to e

Tue Feb 6, 2024

Earnings

amgen quarterly profit rises 15% obesity drug trials are on track.

Tue Feb 6, 2024

Earnings
Potential

amgen non-gaap eps of $4.71 beats by $0.12 revenue of $8.2b beats by $90m.

Tue Feb 6, 2024

Earnings

amgen inc. q4 profit decreases but beats estimates. (rttnews) - amgen inc. (amgn) released earnings for fourth quarter that decreased from last year but beat the street estimates.

Tue Feb 6, 2024

Earnings
Earnings

amgen expects a 2024 sales jump sets sights on obesity market.

Tue Feb 6, 2024

Earnings

amgen quarterly profit rises 15% as horizon deal boosts results. illustration shows the logo of amgen and a robot miniature (reuters) - amgen on tuesday said its adjusted fourth-quarter profit rose 15% driven by a 20% increase in revenue following the bio

Tue Feb 6, 2024

Earnings

amgen rides nine record-making products to a fourth-quarter sales beat. amgen stock dipped late tuesday after the company beat fourth-quarter sales expectations noting nine products hit records. the post amgen rides nine record-making products to a fourth

Tue Feb 6, 2024

Earnings

why amgens weight-loss news just sent lilly to a record high. stock slumped monday — as eli lilly (lly) stock hit a record high — after the biotech company said its experimental weight-loss drug appeared durable for up to 150 days. in one amgen study anim

Mon Feb 5, 2024

Momentum

amgen weight loss drug shows promising early data.

Mon Feb 5, 2024

Activity

tcg labs-soleil raises inaugural fund of over $400 million. san francisco feb. 01 2024 (globe newswire) -- in collaboration with the column group (tcg) today announced it has raised an inaugural fund of over $400 million. designed to support the advancem

Thu Feb 1, 2024

Activity

amgen (amgn) earnings expected to grow: what to know ahead of next weeks release. the market expects amgen (amgn) to deliver a year-over-year increase in earnings on higher revenues when it rep

Tue Jan 30, 2024

Potential

expert outlook: amgen through the eyes of 11 analysts. ratings for amgen (nasdaq:) were provided by 11 analysts in the past three months showcasing a mix of ish and bearish perspectives. the following table summarizes their recent ratings shedding light

Mon Jan 29, 2024

Potential

 
 
 
 
 

Score Tracker

 
 
 
Based on 69 events in the last 90 days from financial news and social media. Last updated Mar 1, 2024 23:12 Wall St. time
 
 

AMGN Total Score

 
 
 
 
 

Similar to AMGN

 
 
 
Symbol
Score
% Change

NVO

Novo Nordisk A/S Com

3.61

+3.72%

124.23

 
 
 
 
 
 
StocksRunner

Discover AMGN Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of AMGN. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our AMGN Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AMGN Stock trends

AMGN Stock performance

AMGN Stock analysis

AMGN investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker